272 related articles for article (PubMed ID: 22955280)
1. Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).
Garg R; Blando J; Perez CJ; Wang H; Benavides FJ; Kazanietz MG
J Biol Chem; 2012 Oct; 287(44):37570-82. PubMed ID: 22955280
[TBL] [Abstract][Full Text] [Related]
2. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
3. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase Cε activity induces anti-inflammatory and anti-apoptotic genes via an ERK1/2- and NF-κB-dependent pathway to enhance vascular protection.
Dumont O; Mylroie H; Bauer A; Calay D; Sperone A; Thornton C; Hamdulay SS; Ali N; Boyle JJ; Choo JR; Samarel AM; Haskard DO; Randi AM; Evans PC; Mason JC
Biochem J; 2012 Oct; 447(2):193-204. PubMed ID: 22849349
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions.
Benavides F; Blando J; Perez CJ; Garg R; Conti CJ; DiGiovanni J; Kazanietz MG
Cell Cycle; 2011 Jan; 10(2):268-77. PubMed ID: 21224724
[TBL] [Abstract][Full Text] [Related]
6. Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.
Meshki J; Caino MC; von Burstin VA; Griner E; Kazanietz MG
J Biol Chem; 2010 Aug; 285(34):26033-40. PubMed ID: 20566643
[TBL] [Abstract][Full Text] [Related]
7. Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis.
Kunnumakkara AB; Ichikawa H; Anand P; Mohankumar CJ; Hema PS; Nair MS; Aggarwal BB
Mol Cancer Ther; 2008 Oct; 7(10):3306-17. PubMed ID: 18852134
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway.
Joo JH; Jetten AM
J Biol Chem; 2008 Jun; 283(24):16391-9. PubMed ID: 18424438
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways.
Shi Y; Tu Z; Tang D; Zhang H; Liu M; Wang K; Calderwood SK; Xiao X
Shock; 2006 Sep; 26(3):277-84. PubMed ID: 16912653
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 induces glut1 transcription through enhanced interaction between Sp1 and NF-kappaB transcription factors.
Kao YS; Fong JC
Cell Signal; 2008 Apr; 20(4):771-8. PubMed ID: 18249093
[TBL] [Abstract][Full Text] [Related]
11. Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis.
Jin HR; Jin SZ; Cai XF; Li D; Wu X; Nan JX; Lee JJ; Jin X
PLoS One; 2012; 7(6):e40355. PubMed ID: 22768286
[TBL] [Abstract][Full Text] [Related]
12. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.
Garg R; Blando JM; Perez CJ; Abba MC; Benavides F; Kazanietz MG
Cell Rep; 2017 Apr; 19(2):375-388. PubMed ID: 28402859
[TBL] [Abstract][Full Text] [Related]
13. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
Takada Y; Singh S; Aggarwal BB
J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer.
Shiota M; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Inokuchi J; Tatsugami K; Uchiumi T; Eto M
Endocr Relat Cancer; 2017 Apr; 24(4):171-180. PubMed ID: 28223364
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester-stimulated NF-kappaB-dependent transcription: roles for isoforms of novel protein kinase C.
Holden NS; Squires PE; Kaur M; Bland R; Jones CE; Newton R
Cell Signal; 2008 Jul; 20(7):1338-48. PubMed ID: 18436431
[TBL] [Abstract][Full Text] [Related]
16. LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-κB pathway in HepG2 cells.
Chen FH; Lu N; Zhang HW; Zhao L; He LC; Sun HP; You QD; Li ZY; Guo QL
Mol Pharmacol; 2012 Nov; 82(5):958-71. PubMed ID: 22909797
[TBL] [Abstract][Full Text] [Related]
17. ERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1.
Mak P; Li J; Samanta S; Mercurio AM
Oncotarget; 2015 Nov; 6(37):40247-54. PubMed ID: 26450901
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
19. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
Dong G; Chen Z; Kato T; Van Waes C
Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk of protein kinase C ε with Smad2/3 promotes tumor cell proliferation in prostate cancer cells by enhancing aerobic glycolysis.
Xu W; Zeng F; Li S; Li G; Lai X; Wang QJ; Deng F
Cell Mol Life Sci; 2018 Dec; 75(24):4583-4598. PubMed ID: 30209539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
